Clinical Trial Update: Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 3 study evaluating the combination of beclomethasone and prednisone for graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Beclomethasone (beclomethasone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Graft Versus Host Disease | Phase 3 | Status: COMPLETED